Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Published:2013-02-01 Issue:5 Volume:19 Page:818-832
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:Current Pharmaceutical Design

Author:

Galvani Elena,Alfieri Roberta,Giovannetti Elisa,Cavazzoni Andrea,La Monica Silvia,Galetti Maricla,Fumarola Claudia,Bonelli Mara,Mor Marco,Tiseo Marcello,J. Peters Godefridus,Giorgio Petronini Pier,Ardizzoni Andrea

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrrolo[2,3-d]pyrimidines as EGFR and VEGFR kinase inhibitors: a comprehensive SAR review;Current Medicinal Chemistry;2023-08-15

2. Reactive Electrophiles and Metabolic Activation;Reference Module in Biomedical Sciences;2023

3. Deciphering the T790M/L858R-Selective Inhibition Mechanism of an Allosteric Inhibitor of EGFR: Insights from Molecular Simulations;ACS Chemical Neuroscience;2021-01-13

4. Protein kinases as targets for developing anticancer agents from marine organisms;Biochimica et Biophysica Acta (BBA) - General Subjects;2021-01

5. Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?;Expert Opinion on Pharmacotherapy;2020-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP